Disorders of Glyoxylate and Oxalate Metabolism

An auditable grouping of distinct DisMech disease entries whose primary defect disrupts glyoxylate, glycolate, oxalate, or calcium oxalate handling. Members include hepatic enzyme deficiencies that overproduce oxalate, HAO1/glycolate oxidase deficiency upstream of glyoxylate production, and transporter defects that alter oxalate handling and calcium oxalate stone risk.

Shared Pathway Shared Mechanism

Why this grouping

The members are kept as separate Disease entries because their proximal mechanisms differ: AGXT and GRHPR are hepatic glyoxylate-metabolism enzyme defects with endogenous oxalate overproduction; HAO1 deficiency is a glycolate oxidase defect that primarily causes hyperglycolic aciduria; and SLC26A1/SLC26A6 are oxalate/anion transporter disorders. A grouping is useful because all five belong to the ICIMD glyoxylate-and-oxalate pathway bucket and share downstream concern for oxalate or calcium oxalate handling, while CAT catalase deficiency is intentionally excluded because it disrupts hydrogen peroxide metabolism instead.

Membership criteria

NECESSARY  (member ⇒ criteria)
A member has a primary genetic defect in a glyoxylate/glycolate metabolic enzyme or an oxalate/anion transporter that materially changes oxalate, glycolate, glyoxylate, or calcium oxalate handling.

Coverage and gaps

6 rows Exact MONDO scope not assessed 4 listed with MONDO ID 2 DisMech outside/no MONDO

No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.

Status DisMech entry MONDO concept In DisMech Has MONDO ID In grouping MONDO Member state Conditions satisfied C1.1 AGXT/alanine-glyoxylate aminotransferase defect. hgnc:341 C1.2 GRHPR/glyoxylate reductase-hydroxypyruvate reductase defect. hgnc:4570 C1.3 HOGA1/4-hydroxy-2-oxoglutarate aldolase defect. hgnc:25155 C1.4 HAO1/glycolate oxidase defect. hgnc:4809 C1.5 SLC26A1/SAT1 anion transporter defect. hgnc:10993 C1.6 SLC26A6 epithelial oxalate transporter defect. hgnc:14472
listed with MONDO ID
SLC26A1-Related Oxalate Transporter Deficiency DISEASE
Differentiating mechanism
Biallelic SLC26A1/SAT1 variants reduce anion transporter activity and cause a recessive Mendelian calcium oxalate nephrolithiasis phenotype. SLC26A1 hgnc:10993oxalate transport GO:0019532
nephrolithiasis susceptibility caused by SLC26A1
MONDO:0020722
yes yes not assessed listed satisfied NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED SATISFIED NOT SATISFIED
listed with MONDO ID
Primary Hyperoxaluria Type 1 DISEASE
Differentiating mechanism
AGXT deficiency blocks hepatic peroxisomal glyoxylate-to-glycine transamination, diverting glyoxylate to oxalate and causing severe endogenous hyperoxaluria. AGXT hgnc:341glyoxylate metabolic process GO:0046487
primary hyperoxaluria type 1
MONDO:0009823
yes yes not assessed listed satisfied SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED
listed with MONDO ID
Primary Hyperoxaluria Type 2 DISEASE
Differentiating mechanism
GRHPR deficiency impairs glyoxylate-to-glycolate and hydroxypyruvate-to-D-glycerate flux, producing increased urinary oxalate and L-glycerate. GRHPR hgnc:4570glyoxylate metabolic process GO:0046487
primary hyperoxaluria type 2
MONDO:0009824
yes yes not assessed listed satisfied NOT SATISFIED SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED
listed with MONDO ID
Primary Hyperoxaluria Type 3 DISEASE
Differentiating mechanism
HOGA1 deficiency blocks the final mitochondrial step of hepatic hydroxyproline degradation (4-hydroxy-2-oxoglutarate aldolase), causing accumulation of 4-hydroxy-2-oxoglutarate and increased endogenous oxalate; PH3 is generally the mildest primary hyperoxaluria with rare progression to kidney failure. HOGA1 hgnc:25155glyoxylate metabolic process GO:0046487
primary hyperoxaluria type 3
MONDO:0013327
yes yes not assessed listed satisfied SATISFIED NOT SATISFIED SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED
DisMech only
HAO1-Related Glycolate Oxidase Deficiency DISEASE
Differentiating mechanism
HAO1/glycolate oxidase deficiency reduces glycolate oxidation to glyoxylate, causing isolated hyperglycolic aciduria and generally benign biochemical disease rather than established recurrent calcium oxalate nephrolithiasis. HAO1 hgnc:4809glyoxylate metabolic process GO:0046487
No MONDO identity yes no not assessed listed satisfied NOT SATISFIED NOT SATISFIED NOT SATISFIED SATISFIED NOT SATISFIED NOT SATISFIED
DisMech only
SLC26A6-Related Hyperoxaluria and Nephrolithiasis DISEASE
Differentiating mechanism
A rare dominant-negative SLC26A6 variant reduces epithelial oxalate transport, causing enteric hyperoxaluria and calcium oxalate nephrolithiasis in the reported family. SLC26A6 hgnc:14472oxalate transport GO:0019532
No MONDO identity yes no not assessed listed satisfied NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED SATISFIED

Source

View YAML on GitHub
Raw YAML
name: Disorders of Glyoxylate and Oxalate Metabolism
display_name: Disorders of Glyoxylate and Oxalate Metabolism
creation_date: "2026-07-06T06:09:44Z"
description: >-
  An auditable grouping of distinct DisMech disease entries whose primary
  defect disrupts glyoxylate, glycolate, oxalate, or calcium oxalate handling.
  Members include hepatic enzyme deficiencies that overproduce oxalate,
  HAO1/glycolate oxidase deficiency upstream of glyoxylate production, and
  transporter defects that alter oxalate handling and calcium oxalate stone
  risk.
grouping_basis:
- SHARED_PATHWAY
- SHARED_MECHANISM
grouping_rationale: >-
  The members are kept as separate Disease entries because their proximal
  mechanisms differ: AGXT and GRHPR are hepatic glyoxylate-metabolism enzyme
  defects with endogenous oxalate overproduction; HAO1 deficiency is a
  glycolate oxidase defect that primarily causes hyperglycolic aciduria; and
  SLC26A1/SLC26A6 are oxalate/anion transporter disorders. A grouping is useful
  because all five belong to the ICIMD glyoxylate-and-oxalate pathway bucket and
  share downstream concern for oxalate or calcium oxalate handling, while CAT
  catalase deficiency is intentionally excluded because it disrupts hydrogen
  peroxide metabolism instead.
membership_criteria:
- description: >-
    A member has a primary genetic defect in a glyoxylate/glycolate metabolic
    enzyme or an oxalate/anion transporter that materially changes oxalate,
    glycolate, glyoxylate, or calcium oxalate handling.
  criteria_semantics: NECESSARY
  logic:
    operator: OR
    operands:
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: AGXT
        term:
          id: hgnc:341
          label: AGXT
      description: AGXT/alanine-glyoxylate aminotransferase defect.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: GRHPR
        term:
          id: hgnc:4570
          label: GRHPR
      description: GRHPR/glyoxylate reductase-hydroxypyruvate reductase defect.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: HOGA1
        term:
          id: hgnc:25155
          label: HOGA1
      description: HOGA1/4-hydroxy-2-oxoglutarate aldolase defect.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: HAO1
        term:
          id: hgnc:4809
          label: HAO1
      description: HAO1/glycolate oxidase defect.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: SLC26A1
        term:
          id: hgnc:10993
          label: SLC26A1
      description: SLC26A1/SAT1 anion transporter defect.
    - criterion_predicate: HAS_GENE
      gene:
        preferred_term: SLC26A6
        term:
          id: hgnc:14472
          label: SLC26A6
      description: SLC26A6 epithelial oxalate transporter defect.
members:
- member: Primary Hyperoxaluria Type 1
  member_type: DISEASE
  disease_term:
    preferred_term: primary hyperoxaluria type 1
    term:
      id: MONDO:0009823
      label: primary hyperoxaluria type 1
  differentiating_mechanisms:
  - description: >-
      AGXT deficiency blocks hepatic peroxisomal glyoxylate-to-glycine
      transamination, diverting glyoxylate to oxalate and causing severe
      endogenous hyperoxaluria.
    gene:
      preferred_term: AGXT
      term:
        id: hgnc:341
        label: AGXT
    biological_processes:
    - preferred_term: glyoxylate metabolic process
      term:
        id: GO:0046487
        label: glyoxylate metabolic process
      modifier: DYSREGULATED
- member: Primary Hyperoxaluria Type 2
  member_type: DISEASE
  disease_term:
    preferred_term: primary hyperoxaluria type 2
    term:
      id: MONDO:0009824
      label: primary hyperoxaluria type 2
  differentiating_mechanisms:
  - description: >-
      GRHPR deficiency impairs glyoxylate-to-glycolate and
      hydroxypyruvate-to-D-glycerate flux, producing increased urinary oxalate
      and L-glycerate.
    gene:
      preferred_term: GRHPR
      term:
        id: hgnc:4570
        label: GRHPR
    biological_processes:
    - preferred_term: glyoxylate metabolic process
      term:
        id: GO:0046487
        label: glyoxylate metabolic process
      modifier: DYSREGULATED
- member: Primary Hyperoxaluria Type 3
  member_type: DISEASE
  disease_term:
    preferred_term: primary hyperoxaluria type 3
    term:
      id: MONDO:0013327
      label: primary hyperoxaluria type 3
  differentiating_mechanisms:
  - description: >-
      HOGA1 deficiency blocks the final mitochondrial step of hepatic
      hydroxyproline degradation (4-hydroxy-2-oxoglutarate aldolase), causing
      accumulation of 4-hydroxy-2-oxoglutarate and increased endogenous oxalate;
      PH3 is generally the mildest primary hyperoxaluria with rare progression
      to kidney failure.
    gene:
      preferred_term: HOGA1
      term:
        id: hgnc:25155
        label: HOGA1
    biological_processes:
    - preferred_term: glyoxylate metabolic process
      term:
        id: GO:0046487
        label: glyoxylate metabolic process
      modifier: DYSREGULATED
- member: HAO1-Related Glycolate Oxidase Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      HAO1/glycolate oxidase deficiency reduces glycolate oxidation to
      glyoxylate, causing isolated hyperglycolic aciduria and generally benign
      biochemical disease rather than established recurrent calcium oxalate
      nephrolithiasis.
    gene:
      preferred_term: HAO1
      term:
        id: hgnc:4809
        label: HAO1
    biological_processes:
    - preferred_term: glyoxylate metabolic process
      term:
        id: GO:0046487
        label: glyoxylate metabolic process
      modifier: DECREASED
- member: SLC26A1-Related Oxalate Transporter Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Biallelic SLC26A1/SAT1 variants reduce anion transporter activity and
      cause a recessive Mendelian calcium oxalate nephrolithiasis phenotype.
    gene:
      preferred_term: SLC26A1
      term:
        id: hgnc:10993
        label: SLC26A1
    biological_processes:
    - preferred_term: oxalate transport
      term:
        id: GO:0019532
        label: oxalate transport
      modifier: DECREASED
- member: SLC26A6-Related Hyperoxaluria and Nephrolithiasis
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      A rare dominant-negative SLC26A6 variant reduces epithelial oxalate
      transport, causing enteric hyperoxaluria and calcium oxalate
      nephrolithiasis in the reported family.
    gene:
      preferred_term: SLC26A6
      term:
        id: hgnc:14472
        label: SLC26A6
    biological_processes:
    - preferred_term: oxalate transport
      term:
        id: GO:0019532
        label: oxalate transport
      modifier: DECREASED
notes: >-
  Created for WP-032 to make the package boundary auditable without lumping
  distinct enzyme and transporter defects into one Disease entry.